For the longest time, BCR-ABL1 fusion was believed to be a hallmark of CML patient samples, but recent studies have described a rare category of AML with BCR-ABL translocation (Kang et al., 2016; Neuendorff et al., 2016; Sampaio et al., 2021). Here, BCR is linked to acute myeloid leukemia.